Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial.

已取消 10 由 Michael 发布于 2026/5/9 15:35:05

DOI:10.1016/S2213-2600(21)00167-3
作者：Klaus F Rabe, Bartolome R Celli, Michael E Wechsler, Raolat M Abdulai, Xiaodong Luo, Maarten M Boomsma, Heribert Staudinger, Julie E Horowitz, Aris Baras, 
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/S2213-2600(21)00167-3

Elsevier

Abstract：Background: Genetic data implicate IL-33 in asthma susceptibility. Itepekimab, a monoclonal antibody targeting IL-33, demonstrated clinical activity in asthma, with potential in chronic obst

应助信息

2026-05-09

Book学术机器人

2026/5/9 15:35:05 未找到该文献，机器人已退出，请等待人工下载

2026/5/9 15:35:05 Book学术AI机器人收到请求，开始寻找文献

2026/5/9 15:35:05 已向机器人发送请求

2026-05-09

Michael 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:SageIs it my overactive imagination? The effects of contextually activated attachment insecurity on sexual fantasies